The Long Non-Coding RNA Landscape of Atherosclerotic Plaques

Currently, cardiovascular diseases continue to be the leading cause of death worldwide; therefore, atherosclerosis remains one of the most crucial public health problems. This chronic and complex disease is considered to be a result of aberrant lipid homeostasis and inflammation of the inner wall of arteries that leads to plaque development. In recent years, a specific class of non-coding RNAs that are characterised by transcript lengths longer than 200 nucleotides, called long non-coding RNAs (lncRNAs), has emerged. Moreover, a growing body of evidence indicates that deregulation of lncRNA expression may contribute to the development of many diseases. Despite continuous efforts in deciphering the molecular basis of atherosclerotic plaque (AP) formation, many aspects of this process remain elusive. Therefore, continuing efforts in this area should remain the highest priority in the coming years. Establishment of a standardised experimental pipeline and validation of lncRNAs as possible relevant biomarkers for cardiovascular disease would enable the translation of gathered findings into clinical practice.

[1]  Peiyang Hu,et al.  HOTAIR alleviates ox-LDL-induced inflammatory response in Raw264.7 cells via inhibiting NF-κB pathway. , 2018, European review for medical and pharmacological sciences.

[2]  Zun-Ping Ke,et al.  Silence of long intergenic noncoding RNA HOTAIR ameliorates oxidative stress and inflammation response in ox‐LDL‐treated human macrophages by upregulating miR‐330‐5p , 2018, Journal of cellular physiology.

[3]  Yuhuang Li,et al.  Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling , 2018, Cardiovascular research.

[4]  R. Yamada,et al.  Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population , 2000, Human Genetics.

[5]  M. Yang,et al.  The suppression of ox-LDL-induced inflammatory cytokine release and apoptosis of HCAECs by long non-coding RNA-MALAT1 via regulating microRNA-155/SOCS1 pathway. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[6]  S. Ghaderian,et al.  Association of Increased Levels of lncRNA H19 in PBMCs with Risk of Coronary Artery Disease , 2018, Cell journal.

[7]  C. Weber,et al.  Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation , 2019, Circulation.

[8]  T. Katsuya,et al.  CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC. , 2012, Biochemical and biophysical research communications.

[9]  Vladimir B Bajic,et al.  LncBook: a curated knowledgebase of human long non-coding RNAs , 2018, Nucleic Acids Res..

[10]  D. Fliser,et al.  Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury , 2018, Scientific Reports.

[11]  I. Bièche,et al.  Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. , 2007, Cancer research.

[12]  J. Wan,et al.  Global transcriptomic study of atherosclerosis development in rats. , 2016, Gene.

[13]  Nesrin Kartal Özer,et al.  Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by interfering with MAPK kinase pathway , 2005, BioFactors.

[14]  G. Schuler,et al.  ANRIL Expression Is Associated With Atherosclerosis Risk at Chromosome 9p21 , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Mulin Jun Li,et al.  Long noncoding RNA LINC00305 promotes inflammation by activating the AHRR-NF-κB pathway in human monocytes , 2017, Scientific Reports.

[16]  N. Sattar,et al.  Smooth Muscle Enriched Long Noncoding RNA (SMILR) Regulates Cell Proliferation , 2016, Circulation.

[17]  Young-Kook Kim,et al.  Identification of long noncoding RNAs involved in muscle differentiation , 2018, PloS one.

[18]  Vladimir B. Bajic,et al.  LncBook: a curated knowledgebase of human long non-coding RNAs , 2018, Nucleic Acids Res..

[19]  Lei Zhang,et al.  MIAT promotes proliferation and hinders apoptosis by modulating miR-181b/STAT3 axis in ox-LDL-induced atherosclerosis cell models. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  L. Holdt,et al.  Recent studies of the human chromosome 9p21 locus, which is associated with atherosclerosis in human populations. , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. Guo,et al.  Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. , 2019, Biochemical and biophysical research communications.

[22]  K. Moore,et al.  The long noncoding RNA CHROME regulates cholesterol homeostasis in primates. , 2019, Nature metabolism.

[23]  M. Hajjari,et al.  HOTAIR: an oncogenic long non-coding RNA in different cancers , 2015, Cancer biology & medicine.

[24]  E. Pinarbasi,et al.  Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque , 2018, Anatolian journal of cardiology.

[25]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Yan Bian,et al.  Association of astragaloside IV‐inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5‐mediated ERK signaling , 2019, Toxicology and applied pharmacology.

[27]  Manolis Kellis,et al.  The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. , 2013, Developmental cell.

[28]  William R. Jeck,et al.  Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk , 2010, PLoS genetics.

[29]  Junyi Guo,et al.  Circulating long noncoding RNA ANRIL downregulation correlates with increased risk, higher disease severity and elevated pro‐inflammatory cytokines in patients with acute ischemic stroke , 2018, Journal of clinical laboratory analysis.

[30]  D. Zheng,et al.  Identification and Initial Functional Characterization of a Human Vascular Cell–Enriched Long Noncoding RNA , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Youyou Yan,et al.  MicroRNA-210 Plays a Critical Role in the Angiogenic Effect of Isoprenaline on Human Umbilical Vein Endothelial Cells via Regulation of Noncoding RNAs , 2016, Chinese medical journal.

[32]  Da-zhu Li,et al.  Thymic Stromal Lymphopoietin Over-Expressed in Human Atherosclerosis: Potential Role in Th17 Differentiation , 2013, Cellular Physiology and Biochemistry.

[33]  Yi Li,et al.  Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis , 2017, Current Medical Science.

[34]  W D Wagner,et al.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[35]  Meng Chen,et al.  LncRNA MALAT1 modulates ox-LDL induced EndMT through the Wnt/β-catenin signaling pathway , 2019, Lipids in Health and Disease.

[36]  Jiefu Yang,et al.  Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox. , 2010, Acta biochimica et biophysica Sinica.

[37]  K. Morris,et al.  Evolutionary conservation of long non-coding RNAs; sequence, structure, function. , 2014, Biochimica et biophysica acta.

[38]  T. Katsuya,et al.  Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. , 2012, Atherosclerosis.

[39]  Zicai Liang,et al.  Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway , 2016, RNA biology.

[40]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[41]  Antonio Federico,et al.  Transcriptome Profiling in Human Diseases: New Advances and Perspectives , 2017, International journal of molecular sciences.

[42]  N. Samani,et al.  Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN , 2019, The Journal of clinical investigation.

[43]  M. Caulfield,et al.  Functional analyses of coronary artery disease associated variation on chromosome 9p21 in vascular smooth muscle cells. , 2012, Human molecular genetics.

[44]  Li-Ping Wang,et al.  Long Noncoding RNA-H19 Contributes to Atherosclerosis and Induces Ischemic Stroke via the Upregulation of Acid Phosphatase 5 , 2019, Front. Neurol..

[45]  Yigang Li,et al.  The lncRNA MALAT1 protects the endothelium against ox‐LDL‐induced dysfunction via upregulating the expression of the miR‐22‐3p target genes CXCR2 and AKT , 2015, FEBS letters.

[46]  Yusuke Nakamura,et al.  Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction , 2006, Journal of Human Genetics.

[47]  B. Lacey,et al.  Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. , 2016, Circulation research.

[48]  Yue Zhao,et al.  Sialidase Deficiency in Porphyromonas gingivalis Increases IL-12 Secretion in Stimulated Macrophages Through Regulation of CR3, IncRNA GAS5 and miR-21 , 2018, Front. Cell. Infect. Microbiol..

[49]  Wei Wu,et al.  New Insights into the Interplay between Non-Coding RNAs and RNA-Binding Protein HnRNPK in Regulating Cellular Functions , 2019, Cells.

[50]  Lin Li,et al.  Upregulation of lincRNA‐p21 in thoracic aortic aneurysms is involved in the regulation of proliferation and apoptosis of vascular smooth muscle cells by activating TGF‐β1 signaling pathway , 2018, Journal of cellular biochemistry.

[51]  L. Lai,et al.  Effects of ANRIL polymorphisms on the likelihood of coronary artery disease: A meta‐analysis , 2018, Journal of cellular biochemistry.

[52]  A. Gabrielsen,et al.  Gene expression signatures, pathways and networks in carotid atherosclerosis , 2016, Journal of internal medicine.

[53]  Z. Tao,et al.  lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA. , 2015, Circulation research.

[54]  M. Hajjari,et al.  Circulating HOTAIR LncRNA Is Potentially Up-regulated in Coronary Artery Disease , 2018, Genomics & informatics.

[55]  Peter F. Stadler,et al.  Alu Elements in ANRIL Non-Coding RNA at Chromosome 9p21 Modulate Atherogenic Cell Functions through Trans-Regulation of Gene Networks , 2013, PLoS genetics.

[56]  Jinglin Cheng,et al.  Overexpression of GAS5 inhibits abnormal activation of Wnt/β‐catenin signaling pathway in myocardial tissues of rats with coronary artery disease , 2018, Journal of cellular physiology.

[57]  Fan Wang,et al.  Long noncoding RNA ANRIL regulates endothelial cell activities associated with coronary artery disease by up-regulating CLIP1, EZR, and LYVE1 genes , 2019, The Journal of Biological Chemistry.

[58]  M. Daemen,et al.  Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery. , 2007, Physiological genomics.

[59]  S. Ghaderian,et al.  Association between Long Noncoding RNA ANRIL Expression Variants and Susceptibility to Coronary Artery Disease , 2018, International journal of molecular and cellular medicine.

[60]  Zhenyu Xu,et al.  LncRNA MALAT1 regulates oxLDL-induced CD36 expression via activating β-catenin. , 2018, Biochemical and biophysical research communications.

[61]  Kun Qu,et al.  BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. , 2012, Genome research.

[62]  M. Mann,et al.  Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans , 2016, Nature Communications.

[63]  P. Khavari,et al.  The functions and unique features of long intergenic non-coding RNA , 2017, Nature Reviews Molecular Cell Biology.

[64]  G. Lemesle,et al.  Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure , 2014, Circulation research.

[65]  Zhuo Zhao,et al.  Long intergenic noncoding RNA 00305 sponges miR-136 to regulate the hypoxia induced apoptosis of vascular endothelial cells. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[66]  M. Nasiri,et al.  Association of the rs555172 polymorphism in SENCR long non-coding RNA and atherosclerotic coronary artery disease , 2017, Journal of cardiovascular and thoracic research.

[67]  Chongbao Wang,et al.  LncRBA GSA5, up‐regulated by ox‐LDL, aggravates inflammatory response and MMP expression in THP‐1 macrophages by acting like a sponge for miR‐221 , 2018, Experimental cell research.

[68]  Michael Thomas,et al.  MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.

[69]  Jinlan Duan,et al.  MALAT1/miR-15b-5p/MAPK1 mediates endothelial progenitor cells autophagy and affects coronary atherosclerotic heart disease via mTOR signaling pathway , 2019, Aging.

[70]  Jin Yao,et al.  Long Noncoding RNA-GAS5: A Novel Regulator of Hypertension-Induced Vascular Remodeling. , 2016, Hypertension.

[71]  C. Haudenschild,et al.  H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. , 1996, The Journal of clinical investigation.

[72]  R. Zeng,et al.  The long non-coding RNA MALAT1 activates Nrf2 signaling to protect human umbilical vein endothelial cells from hydrogen peroxide. , 2018, Biochemical and biophysical research communications.

[73]  G. Hannon,et al.  lncRNAs in development and disease: from functions to mechanisms , 2017, Open Biology.

[74]  Taibing Fan,et al.  Knockdown of growth‐arrest specific transcript 5 restores oxidized low‐density lipoprotein‐induced impaired autophagy flux via upregulating miR‐26a in human endothelial cells , 2019, European journal of pharmacology.

[75]  G. Dorn.  LIPCAR: a mitochondrial lnc in the noncoding RNA chain? , 2014, Circulation research.

[76]  Y. Devaux,et al.  Long non-coding RNAs in the atherosclerotic plaque. , 2017, Atherosclerosis.

[77]  D. Rader,et al.  Mining the Stiffness-Sensitive Transcriptome in Human Vascular Smooth Muscle Cells Identifies Long Noncoding RNA Stiffness Regulators , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[78]  Yue Wang,et al.  Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction , 2016, Cell Death and Disease.

[79]  Howard Y. Chang,et al.  A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression , 2011, Nature.

[80]  He Li,et al.  LncRNA BANCR facilitates vascular smooth muscle cell proliferation and migration through JNK pathway , 2017, Oncotarget.

[81]  Noorul Amin,et al.  Evaluation of deep learning in non-coding RNA classification , 2019, Nature Machine Intelligence.

[82]  P. Lv,et al.  The interplay of LncRNA ANRIL and miR‐181b on the inflammation‐relevant coronary artery disease through mediating NF‐κB signalling pathway , 2018, Journal of cellular and molecular medicine.

[83]  S. Dimmeler,et al.  Long Noncoding RNA MALAT1 Regulates Endothelial Cell Function and Vessel Growth , 2014, Circulation Research.

[84]  L. Mao,et al.  LncRNA MIAT sponges miR-149-5p to inhibit efferocytosis in advanced atherosclerosis through CD47 upregulation , 2019, Cell Death & Disease.

[85]  Stefan Lorkowski,et al.  Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. , 2008, Human molecular genetics.

[86]  R. Salehi,et al.  Non-invasive diagnosis of early-onset coronary artery disease based on cell type-specific gene expression analyses. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[87]  Guocheng Yuan,et al.  LincRNA-p21 Regulates Neointima Formation, Vascular Smooth Muscle Cell Proliferation, Apoptosis, and Atherosclerosis by Enhancing p53 Activity , 2014, Circulation.

[88]  G. Heydecke,et al.  Roles of the Chr.9p21.3 ANRIL Locus in Regulating Inflammation and Implications for Anti-Inflammatory Drug Target Identification , 2018, Front. Cardiovasc. Med..

[89]  L. Yi,et al.  Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis , 2017, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[90]  Pan Jx.  LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. , 2017 .

[91]  K. Dakshinamurti,et al.  Atherosclerosis risk factors: the possible role of homocysteine , 2000, Molecular and Cellular Biochemistry.

[92]  A. Tuttolomondo,et al.  Atherosclerosis as an inflammatory disease. , 2012, Current pharmaceutical design.

[93]  J-X Pan.  LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway. , 2017, European review for medical and pharmacological sciences.

[94]  Wei Zhang,et al.  Long noncoding RNA LINC00968 promotes endothelial cell proliferation and migration via regulating miR‐9‐3p expression , 2018, Journal of cellular biochemistry.

[95]  Linhui Chen,et al.  Identification of Key lncRNAs Associated With Atherosclerosis Progression Based on Public Datasets , 2019, Front. Genet..

[96]  Bihong Liao,et al.  Long noncoding RNA HOTTIP promotes endothelial cell proliferation and migration via activation of the Wnt/β‐catenin pathway , 2018, Journal of cellular biochemistry.

[97]  Lin Zhao,et al.  Long noncoding RNA H19 promotes vascular remodeling by sponging let-7a to upregulate the expression of cyclin D1. , 2019, Biochemical and biophysical research communications.

[98]  P. Tontonoz,et al.  Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function , 2018, Circulation research.

[99]  E. Cuppen,et al.  Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes , 2014, Genome Biology.

[100]  V. Fuster,et al.  Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability , 2016, Nature Communications.

[101]  G. Lemesle,et al.  The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients , 2014 .

[102]  Howard Y. Chang,et al.  Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.

[103]  Xia Wang,et al.  The roles of ANRIL polymorphisms in coronary artery disease: a meta-analysis , 2019, Bioscience reports.

[104]  S. Kovačić,et al.  Genetic Susceptibility to Atherosclerosis , 2012, Stroke research and treatment.

[105]  Yachen Zhang,et al.  MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145 , 2017, Cellular Physiology and Biochemistry.

[106]  D. Song,et al.  The long noncoding RNA MALAT1 regulates the lipopolysaccharide‐induced inflammatory response through its interaction with NF‐κB , 2016, FEBS letters.

[107]  Zhijian Yang,et al.  Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population , 2017, Scientific Reports.

[108]  L. Holdt,et al.  Long Noncoding RNA ANRIL: Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis , 2018, Front. Cardiovasc. Med..

[109]  Chong Wu,et al.  NEXN Is a Novel Susceptibility Gene for Coronary Artery Disease in Han Chinese , 2013, PloS one.

[110]  K. Moore,et al.  The long noncoding RNA CHROME regulates cholesterol homeostasis in primate , 2018, Nature Metabolism.

[111]  T. Sun,et al.  Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function , 2013, Neuroscience.

[112]  S. Ylä-Herttuala,et al.  Transcriptional Profiling of Hypoxia-Regulated Non-coding RNAs in Human Primary Endothelial Cells , 2018, Front. Cardiovasc. Med..

[113]  B. Erman,et al.  Long noncoding RNA (lincRNA), a new paradigm in gene expression control , 2016, Functional & Integrative Genomics.

[114]  Y. Zhang,et al.  LncRNA‐RP11‐714G18.1 suppresses vascular cell migration via directly targeting LRP2BP , 2018, Immunology and cell biology.

[115]  Q. She,et al.  Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis , 2018, Cellular Physiology and Biochemistry.

[116]  Y. Zhong,et al.  Thymic stromal lymphopoietin-induced HOTAIR activation promotes endothelial cell proliferation and migration in atherosclerosis , 2017, Bioscience reports.

[117]  Carolyn J. Brown,et al.  The functional role of long non-coding RNA in human carcinomas , 2011, Molecular Cancer.

[118]  J. Miano,et al.  SENCR stabilizes vascular endothelial cell adherens junctions through interaction with CKAP4 , 2018, Proceedings of the National Academy of Sciences.

[119]  M. Gassmann,et al.  Analysis of hypoxia-induced noncoding RNAs reveals metastasis-associated lung adenocarcinoma transcript 1 as an important regulator of vascular smooth muscle cell proliferation , 2017, Experimental biology and medicine.

[120]  P. Zheng,et al.  Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis , 2017, PloS one.

[121]  A. Pyle,et al.  Inverted repeat Alu elements in the human lincRNA-p21 adopt a conserved secondary structure that regulates RNA function , 2016, Nucleic acids research.

[122]  R. Ross,et al.  Response to injury and atherogenesis. , 1977, The American journal of pathology.

[123]  Hailing Cheng,et al.  H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells , 2018, Journal of Biomedical Science.

[124]  Xinguang Liu,et al.  Association of lincRNA-p21 Haplotype with Coronary Artery Disease in a Chinese Han Population , 2016, Disease markers.

[125]  Wei Gao,et al.  Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population. , 2015, Mutation research.

[126]  J. Xie,et al.  Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes. , 2009, Acta biochimica et biophysica Sinica.

[127]  J. Rinn,et al.  A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response , 2010, Cell.

[128]  Manhua Liu,et al.  Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[129]  G. Angelini,et al.  A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[130]  P. Puthanveetil,et al.  Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells , 2015, Journal of cellular and molecular medicine.

[131]  Junyuan Lv,et al.  Long noncoding RNA H19-derived miR-675 aggravates restenosis by targeting PTEN. , 2017, Biochemical and biophysical research communications.

[132]  Fanming Meng,et al.  Expression status and clinical significance of lncRNA APPAT in the progression of atherosclerosis , 2018, PeerJ.